Tag Archives: Institute of Mental Health: University of Nottingham

Development of Standardised Intervention Outcome Measures for Dementia Prevention (PLoS One / HTA)

Posted on July 25, 2017 by Dementia and Elderly Care News

Summary The following articles present work towards establishing a consensus on the most suitable outcomes to be measured when assessing “disease modification” (or the lack of it) in response to interventions intended to delay or prevent the progress of dementia. … Continue reading →

Posted in Alzheimer's Society, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Integrated Care, Mental Health, Models of Dementia Care, Quick Insights, Standards, Systematic Reviews, UK | Tagged Activities of Daily Living (ADLs), Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog), Alzheimer's Society, Alzheimer’s Disease Clinical Trials, and Health Psychology: University College London, Assessment of Quality of Life, Aston Research Centre for Healthy Ageing: Aston University, Aston University, Bangor University, Biological Markers, Biomarkers, Brighton and Sussex Medical School, Cambridge Institute of Public Health: University of Cambridge, Camden and Islington NHS Foundation Trust, Cardiff University, Centre for Dementia Studies: Brighton and Sussex Medical School, Centre for Public Health: Queen's University Belfast, Centre for Research in Primary and Community Care: University of Hertfordshire, Clinical Dementia Rating (CDR), Clinical Dementia Rating Scale, Core Outcome Measures in Effectiveness Trials, Dementia Quality of Life (DEMQOL), Dementia Quality of Life Measure, Dementia Services Development Centre Wales: Bangor University, Department of Psychiatry and Psychotherapy: Ludwig-Maximilians-Universität München, Department of Psychiatry and Psychotherapy: Technische Universität München, Department of Psychiatry: University of Cambridge, Disability Assessment for Dementia-DAD, Disease Modification, Disease Modification Trials, Disease-Modifying Trials in Mild-to-Moderate Dementia, Division of Psychiatry: University College London, Division of Psychology and Language Sciences: University College London, Drug Trials Failure Rate, Faculty of Health and Social Care: University of Hull, Faculty of Medicine: Imperial College London, Germany, Health Technology Assessment (HTA) Programme, Health Technology Assessment Study, Health Technology Assessments, Imperial College London, Institute of Brain Behaviour and Mental Health: University of Manchester, Institute of Health and Society: Newcastle University, Institute of Mental Health: University of Nottingham, International Consortium for Health Outcomes Measurement, Kings College London, Leeds Beckett University, Ludwig-Maximilians-Universität München, Magnetic Resonance Imaging (MRI), Measurement of Successes and Failures of Dementia Treatments, Measuring the Impact of Interventions to Reduce Alzheimer’s Disease, Mini Mental State Examination (MMSE), National Institute for Health Research (NIHR), National Institute for Health Research: Health Technology Assessment Programme, Neuropsychiatric Inventory (NPI), Neuropsychiatric Inventory (NPI) Agitation / Aggression Scale, Neuropsychiatric Inventory Agitation / Aggression Domain (NPI), Neuropsychiatric Symptoms, Neuropsychiatric Symptoms in People With Dementia, Neuroscience Research Centre - St. George's: University of London, Newcastle University, NIHR Health Technology Assessment (HTA) Programme, NIHR HTA: Health Technology Assessment programme, North Thames CLAHRC, Norwich Medical School: University of East Anglia, Nuffield Department of Population Health: University of Oxford, Opportunities for Standardisation, Outcome Measures for Disease-Modifying Trials in Mild-to-Moderate Dementia, Outcome Validation, Oxford Health NHS Foundation Trust, Patient and Public Involvement (PPI), PenCLAHRC: University of Exeter Medical School, Personal Social Services Research Unit: University of Manchester, Potential Treatment for Alzheimer’s Disease, Queen's University Belfast, Research Department of Clinical Educational, Research Institute for the Care of Older People (RICE): University of Bath, ScHARR: University of Sheffield, School of Clinical Sciences: University of Bristol, School of Health and Community Studies: Leeds Beckett University, School of Healthcare Sciences: Cardiff University, School of Medicine: University of Southampton, School of Psychology: University of Exeter, School of Public Health: Imperial College London, sMRI (Structural Magnetic Resonance Imaging), Standardisation, Systematic Reviews and Meta-Analyses, Technische Universität München, United Kingdom, University College London, University of Bath, University of Bristol, University of Cambridge, University of East Anglia, University of Exeter, University of Exeter Medical School, University of Hertfordshire, University of Hull, University of London, University of Manchester, University of Nottingham, University of Oxford, University of Sheffield, University of Southampton, University of Warwick, Warwick Clinical Trials Research Unit: University of Warwick, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

On the Benefits of Supportive Social Networks (Journal of Alzheimers Disease)

Posted on May 16, 2017 by Dementia and Elderly Care News

Summary Data from the English Longitudinal Study of Ageing (ELSA) has been used to demonstrate that positive social support from friends, family etc. is associated statistically with a reduced risk of developing dementia. Conversely, negative social support appears to increase … Continue reading →

Posted in Community Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Mental Health, Quick Insights, Statistics, UK, Universal Interest | Tagged Benefits of Supportive Social Networks, Centre for Primary Health and Social Care: London Metropolitan University, Dementia Risk Factors, Department of Applied Health Research: University College London, Department of Epidemiology and Public Health (University College London), Emotional and Social Isolation, English Longitudinal Study of Ageing (ELSA), Epidemiology, Epidemiology and Statistics, Feelings Relating to Social Relationships, Indirect Pathways by Which Social Connections Influence Disease Morbidity and Mortality, Influence of Social Connections on Disease Morbidity and Mortality, Institute of Mental Health: University of Nottingham, Involvement in Social Relationships, Journal of Alzheimer's Disease, Lifestyle Risk Factors, London, London Metropolitan University, Loneliness and Social Isolation, Modifiable Risk Factors, Negative Social Support, Norwich, Norwich Medical School: University of East Anglia, Nottingham, Personalised Social Interaction, Positive Social Support, Potentially Modifiable Socio-Environmental Risk Factors for Dementia, Professor Martin Orrell, Promoting Independence in Dementia (PRIDE) Programme, Psychosocial and Lifestyle-Related Risk Factors, Psychosocial Protective and Risk Factors, Satisfaction with Social Relationships and / or Participation, Social Connectedness, Social Epidemiology, Social Interaction, Social Isolation, Social Isolation: Social Economic and Environmental Determinant (SEED) of Health, Social Networks, Social Relationships, Social Support, Socio-Environmental Risk Factors for Dementia, Structural and / or Functional Aspects of Social Relationships, Supportive Social Networks, Supportive Social Relationships, University College London, University of East Anglia, University of Nottingham | Leave a comment

Re-Evaluating the Effectiveness of Joint Reminiscence Groups: the REMCARE Trial (PLoS One)

Posted on August 31, 2016 by Dementia and Elderly Care News

Summary The REMCARE Trial investigated the relative benefits and effectiveness of joint reminiscence groups, i.e. reminiscence therapy interventions involving people with dementia and their family carers together. The researchers did not find evidence supporting the clinical effectiveness or cost-effectiveness of … Continue reading →

Posted in Commissioning, Community Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK, Universal Interest, Wales | Tagged Activities of Daily Living, Aneurin Bevan Health Board: Ystrad Mynach Hospital, Autobiographical Memory, Autobiographical Memory Interview (AMI), Bangor, Bangor University, Bradford, Bradford Dementia Group: University of Bradford, Carer Patient Dyad Relationship Quality, Carer Stress, Centre for Economics and Policy in Health: Bangor University, Centre for Health Information Research and Evaluation: Swansea University, Clinical Psychology, Community Mental Health, Consort Checklist for REMCARE Study, Cornell Scale for Depression in Dementia (CSDD), Cost-Effectiveness, Cost-Effectiveness Analyses, Cost-Effectiveness in Health Care, Cost-Utility Analyses, Dementia Care Research Faculty of Health and Social Care: University of Hull, Dementia Services Development Centre Wales: Bangor University, Division of Psychiatry: University College London, Family Carers, General Health Questionnaire (GHQ-28), Group Reminiscence Therapy, Hospital Anxiety and Depression Scale (HADS), Hull, Institute of Mental Health: University of Nottingham, ISRCTN Registry No. ISRCTN42430123, Joint Interventions, Joint Reminiscence Groups, Manchester, NHS Community Mental Health, NHS Memory Clinics, North Wales Organisation for Randomised Trials in Health and Social Care: Bangor University, Nottingham, ORCID, People With Dementia and Family Carers, PLoS One, Professor Martin Orrell, Psychological Distress in Carers, Quality of Life and Relationship Quality for People With Dementia, Quality of the Carer–Patient Relationship (QCPR), Rating Anxiety In Dementia (RAID), Relative's Stress Scale, REMCARE Trial, REMCARE: Pragmatic Multi-Centre Randomised Trial of Reminiscence Groups for People with Dementia and their Family Carers, REMCARE: Reminiscence Groups for People With Dementia and Their Family Caregivers, Reminiscence, Reminiscence and Sensory Stimulation, Reminiscence Groups for People with Dementia, Reminiscence Services, Reminiscence Therapy, School of Nursing Midwifery and Social Work: University of Manchester, Self-Reported Quality of Life For Persons With Dementia (QoL-AD), Swansea, Swansea University, University College London, University of Bradford, University of Hull, University of Manchester, University of Nottingham, West Wales Organisation for Rigorous Trials in Health: Swansea University, Ystrad Mynach Hospital (Caerphilly) | Leave a comment

Rates of Dementia Diagnoses Lower Than Predicted (BBC News / Nature Communications)

Posted on April 20, 2016 by Dementia and Elderly Care News

Summary The predicted explosion of dementia cases, often referred to as the “dementia time-bomb”, could be less severe than previously thought, in men at least. Based on latest data from Cambridgeshire, Nottingham and Newcastle, there could be 40,000 fewer cases … Continue reading →

The Pros and Cons of Screening (Sense About Science / BMJ / BMC Geriatrics / BBC News)

Posted on July 19, 2015 by Dementia and Elderly Care News

Summary The brief “Making Sense of Screening” guide attempts to inform public expectations about screening programmes. It offers insights into the limitations of what screening programmes are sometimes able to deliver. Common misconceptions about how screening works are addressed, with … Continue reading →

Posted in BBC News, Charitable Bodies, Commissioning, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, Models of Dementia Care, Quick Insights, UK, Universal Interest | Tagged Academic Unit of Psychiatry: University of Bristol, Advisory Board of Breast Screening, Association for Clinical Biochemistry and Laboratory Medicine, BBC Health News, BMJ, British Medical Journal (BMJ), Cambridge Institute of Public Health: University of Cambridge, Case Finding, Cognitive Screening, Dementia Screening, Dementia Screening Debate, Division of Psychiatry: University College London, Early Screening, Evidence Based Medicine Matters, Faculty of Medicine and Health Sciences: University of East Anglia, False Alarms, False Negatives, False Positives, Great Prostate Mistake, Great Prostate Mistake (PSA sic Promoting Stress and Anxiety), Harms From Overdiagnosis, Health Screening Programmes, Hedley Glencross: Portsmouth Hospitals NHS Trust, Institute of Biomedical Science, Institute of Mental Health: University of Nottingham, Joe O’Meara: Association for Clinical Biochemistry and Laboratory Medicine, Making Sense of Testing, Making Sense of Uncertainty, Mass Screening, National Breast Cancer Screening Programme, National Screening Committee, Nordic Cochrane Centre in Copenhagen, Overdiagnosis (Speculative Concept), Overdiagnosis and Overtreatment, PSA (Prostate Specific Antigen), Public Attitudes Expectations and Preferences, QRISK2 Calculator, Research Department of Primary Care and Population Health: University College London, Risk of Overdiagnosis Associated With Screening, Síle Lane: Sense About Science, Screening, Screening for Dementia, Screening Populations, Screening Programmes, Screening Tests, Screening: Counter-Intuitive Evidence, Sense About Science, Targeted Screening, UCL Medical School, UK National Screening Committee, University College London, University of Bristol, University of Cambridge, University of East Anglia, University of Nottingham, Watchful Waiting | Leave a comment

Tag Archives: Institute of Mental Health: University of Nottingham

The Pros and Cons of Screening (Sense About Science / BMJ / BMC Geriatrics / BBC News)

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites